Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Avanz Phleum Pratense Maintenance Dose

NCT01438827 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT01438827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01438827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Avanz Phleum Pratense Maintenance Dose
Lead sponsor
ALK-Abelló A/S
Phase
Phase 2/3
Overall status
Completed
Start date
September 30, 2011
Completion date
January 31, 2013
Enrollment
450 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinoconjunctivitis